Stocks and Investing Stocks and Investing
Thu, May 22, 2014
Wed, May 21, 2014
Tue, May 20, 2014
Mon, May 19, 2014

Matt Miksic Upgraded (ABT) to Buy on, May 19th, 2014


Published on 2024-10-25 05:03:20 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Upgraded "Abbott Laboratories" (ABT) to Buy on, May 19th, 2014.

Matt has made no other calls on ABT in the last 4 months.



There is 1 other peer that has a rating on ABT. Out of the 1 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matt


  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $42 on, Thursday, January 23rd, 2014

Contributing Sources